Bladder cancer is on the rise today and so is the progress in the medical field for its treatment. Bladder cancer is a disease in which the malignant cells ( which grow and spread in the body ) are formed in the tissues of the bladder. The plan of a bladder as a body organ is the storage and release of urine. It is a tunnel organ in the lower stomach having a well-founded wall that makes it larger or smaller. Urine is the residual serum made by the kidneys when the vermilion is cleaned and it is stored in the bladder. The urine passes from the two kidneys into the bladder ended two tubes called ureters. When the bladder is cleared during urination, the urine goes from the bladder to the guise of the body fini else cylinder called the urethra. Much bother has to be taken when one is suffering from bladder cancer. But a new study research has found that current guidelines recommending load to be taken in position of giant - grade noninvasive bladder cancer is not followed and forasmuch as the number is on rise. The study indicates that efforts are needed to spot and beaten barriers to providing optimal solicitude to patients with this cancer. The upraised grade noninvasive bladder cancer has alpine recurrence chances up to 70 % even touching treatment and 50 % chances of becoming a more invasive tumor. This indulgent of cancer has to have capable treatment because it can have forceful consequences. If the tumor recurs and remains noninvasive, manifold operations have to be done, if it recurs and progresses to invasive cancer, there is a risk of cancer spread and the bladder may have to be removed and chemotherapy and radiation treatments may have to be taken. Even if treatment is obsessed, the medical guidelines for advocating such medicine should be followed, like delivering anticancer chemotherapy these days into the bladder ( intravesical therapy ) in uniformity to minimize recurrence and progression of this cancer. An protracted replace - up should and be done with cytology and cystoscopy. Even in this critical site, there is a ray of hope, as there has been a research which suggests that genetic variation reduces the risk of bladder cancer. A common genetic variation links to both bladder cancer risk and to the length of protective caps found on the ends of chromosomes as the research states. These endings or tips, called telomeres, guard against chromosomal damage and genomic instability that can lead to cancer and other diseases. One should be aware and alert about the latest updates in medical field for a safe and healthy living.